Skip to content

Metoclopramide

Published: July 26, 2026Updated: August 24, 2026

Metoclopramide is a prokinetic and antiemetic medication used to treat nausea, vomiting, and gastrointestinal motility disorders by blocking dopamine receptors and enhancing motility.

Quick summary

Metoclopramide is a prokinetic agent used to relieve nausea, vomiting, and stomach motility problems.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 24, 2026Editorial policy
BOXED WARNING

This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.

Key facts at a glance

ATC
A03FA01
RxNorm
6915
Generic
Metoclopramide
Class
atc-a03
Brands
Pileran, Gimoti, Metozolv, Reglan
Availability
rx
Lactation
unknown
Routes
oral, nasal
Forms
injection, prefilled syringe, tablet, solution, spray
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
10mg three to four times daily
Maximum
consult physician
Frequency
every 6 to 8 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
0.1-0.2 mg/kg/dose up to 4 times daily
Maximum
consult physician
Frequency
every 6 to 8 hours as needed
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
5mg three to four times daily
Maximum
consult physician
Frequency
every 6 to 8 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Doses exceeding 1000 mg may cause serious toxicity in adults
Chronic overdose: Prolonged use at doses above 30-40 mg daily may lead to cumulative toxicity including tardive dyskinesia and neurological effects
Immediate actions
Gastric lavage within 1-2 hours of ingestion, activated charcoal, supportive care, monitor cardiac function
Antidote
No specific antidote exists; benztropine or diphenhydramine may be used for extrapyramidal symptoms(Supportive care is primary treatment; symptom-directed interventions are effective)
Poison Control: 1-800-222-1222

Special Populations

10 groups
⚠

pregnancy

first trimester
caution
FDA Category
B
Dose Adjustment

use lowest effective dose

Key Recommendations

use only if benefits outweigh potential risks; commonly used for hyperemesis gravidarum when other treatments fail

Monitor

monitor for maternal side effects

Use with caution and monitor for adverse effects.

⚠

pregnancy

second third trimester
caution
FDA Category
B
Dose Adjustment

use lowest effective dose

Key Recommendations

use only when clearly needed; avoid prolonged use

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

lactation

breastfeeding
caution
FDA Category
N
Dose Adjustment

avoid high doses

Key Recommendations

small amounts excreted in breast milk; monitor infant for drowsiness and feeding problems

Monitor

observe infant for sedation, irritability, or feeding difficulties

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

reduce dose by at least 50%

Key Recommendations

increased sensitivity to extrapyramidal symptoms and sedation; start with lowest dose

Monitor

monitor for tardive dyskinesia, sedation, and hypotension

Use with caution and monitor for adverse effects.

✗

pediatric_age

under 2 years
contraindicated
FDA Category
N
Dose Adjustment

not recommended

Key Recommendations

avoid in children under 2 years due to risk of severe extrapyramidal reactions

Monitor

close monitoring if use is absolutely necessary

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pediatric_age

2 to 18 years
caution
FDA Category
N
Dose Adjustment

weight-based dosing, max 0.5mg/kg/day

Key Recommendations

use for chemotherapy-induced nausea only; avoid for other indications in children

Monitor

monitor for extrapyramidal symptoms especially in first 24-48 hours

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild
caution
FDA Category
N
Dose Adjustment

no adjustment needed for CrCl > 40 mL/min

Key Recommendations

use standard dosing with monitoring

Monitor

monitor renal function periodically

Use with caution and monitor for adverse effects.

⚠

renal_impairment

moderate severe
caution
FDA Category
N
Dose Adjustment

reduce dose by 50% for CrCl < 40 mL/min

Key Recommendations

reduce dose and extend dosing interval

Monitor

monitor renal function and adjust dose accordingly

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild moderate
caution
FDA Category
N
Dose Adjustment

consider dose reduction

Key Recommendations

use with caution; metoclopramide is metabolized hepatically

Monitor

monitor for increased side effects

Use with caution and monitor for adverse effects.

✗

hepatic_impairment

severe
unsafe
FDA Category
N
Dose Adjustment

avoid or use minimal dose

Key Recommendations

avoid use in severe hepatic impairment due to limited data

Monitor

close monitoring if use is necessary

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

prescribingFDA
2023

FDA approval year

Value:1979

General prescribing information

drug_classWHO
2023

Drug class

Value:Dopamine antagonist (Prokinetic)

Drug class information

usageMedical guidelines
2023

Common uses

Value:Nausea, vomiting, gastroparesis, migraine-associated nausea

Common therapeutic uses

pharmacologyFDA
2023

Bioavailability

Value:80%

Pharmacokinetic properties

Metoclopramide is used to treat nausea and vomiting (including post-operative and chemotherapy-induced), gastroesophageal reflux disease (GERD), gastroparesis (delayed stomach emptying), and to facilitate gastric emptying procedures.

Metoclopramide works as a dopamine D2 receptor antagonist in the brain and gastrointestinal tract. It also has 5-HT4 agonist and weak 5-HT3 antagonist properties, which help increase gastric contractions, accelerate stomach emptying, and reduce nausea signals.

Common side effects include drowsiness, fatigue, and movement disorders. Rare but serious risks include tardive dyskinesia (especially with long-term use) and neuroleptic malignant syndrome. It should be avoided in patients with Parkinson's disease, pheochromocytoma, or bowel obstruction. Use with caution in elderly patients and those with a history of seizures.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy